Champions Oncology to Announce Fourth Quarter and Year-End Financial Results on Thursday, July 18, 2024

Rhea-AI Summary

Champions Oncology (NASDAQ: CSBR), a global provider of preclinical and clinical research services, will announce its financial and operational results for Q4 and the fiscal year ended April 30, 2024, on July 18, 2024, after market close.

The company will hold a conference call at 4:30 P.M. EST (1:30 P.M. PST) to discuss the results. Participants can join the call domestically by dialing 888-506-0062 or internationally at 973-528-0011 using access code 135832. A replay will be available within 72 hours by dialing 877-481-4010 (Domestic) or 919-882-2331 (International), passcode: 50895, or through the investor section of the company's website.

HACKENSACK, NJ / ACCESSWIRE / July 11, 2024 / Champions Oncology, Inc. (NASDAQ:CSBR), a global preclinical and clinical research services provider that offers end-to-end oncology solutions, will report its financial and operational results for the fourth quarter and year-ended April 30, 2024, on Thursday, July 18, 2024, after market close. The company will host a conference call to discuss the results that day at 4:30 P.M. EST (1:30 P.M. PST). To join the call dial 888-506-0062 (Domestic) or 973-528-0011 (International) and enter the access code 135832. A replay of the call will be available by dialing 877-481-4010 (Domestic) or 919-882-2331 (International) and entering passcode: 50895, or by accessing the investors section of the company's website within 72 hours.

About Champions Oncology, Inc.

Champions Oncology is a global preclinical and clinical research services provider that offers end-to-end oncology R&D solutions to biopharma organizations. With the largest and most annotated bank of clinically relevant patient-derived xenograft (PDX) and primary hematological malignancy models, Champions delivers innovative highest-quality data through proprietary in vivo and ex vivo platforms. Through its large portfolio of cutting-edge bioanalytical platforms, groundbreaking data platform and analytics, and scientific excellence, Champions enables the advancement of preclinical and clinical oncology drug discovery and development programs worldwide. For more information, please visit www.ChampionsOncology.com.

Media Contact:
Rachel Bunting, MS, MBA
VP, Global Marketing
Marketing@ChampionsOncology.com

Website: www.championsoncology.com
Facebook: www.facebook.com/championsoncology/
LinkedIn: www.linkedin.com/company/champions-oncology-inc-/
Twitter: www.twitter.com/ChampionsOncol1
Instagram: www.instagram.com/championsoncology/

SOURCE: Champions Oncology, Inc.

View the original press release on accesswire.com

FAQ

When will Champions Oncology announce their Q4 and year-end 2024 financial results?

Champions Oncology will announce their Q4 and year-end 2024 financial results on July 18, 2024, after market close.

How can I join the Champions Oncology Q4 and year-end 2024 earnings call?

You can join the earnings call on July 18, 2024, at 4:30 P.M. EST (1:30 P.M. PST) by dialing 888-506-0062 domestically or 973-528-0011 internationally, with access code 135832.

What is the access code for Champions Oncology's earnings call on July 18, 2024?

The access code for the earnings call is 135832.

Will there be a replay available for Champions Oncology's Q4 and year-end 2024 earnings call?

Yes, a replay will be available within 72 hours by dialing 877-481-4010 domestically or 919-882-2331 internationally, using passcode 50895, or via the investor section of the company's website.

What is the ticker symbol for Champions Oncology?

The ticker symbol for Champions Oncology is CSBR.